Aldose reductase inhibitors from Litchi chinensis Sonn
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Sung-Jae | - |
dc.contributor.author | Park, Won-Hwan | - |
dc.contributor.author | Park, Sun-Dong | - |
dc.contributor.author | Moon, Hyung-In | - |
dc.date.accessioned | 2021-09-08T15:23:46Z | - |
dc.date.available | 2021-09-08T15:23:46Z | - |
dc.date.created | 2021-06-10 | - |
dc.date.issued | 2009-08 | - |
dc.identifier.issn | 1475-6366 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/119637 | - |
dc.description.abstract | Diabetes is one of the major risk factors for cataract. Aldose reductase has been reported to play an important role in sugar-induced cataract. In this study, we conducted pharmacological investigations upon experimental rat lenses using extracts of the fruits of Litchi chinensis (Sapindaceae). Of the extracts and organic fractions of L. chinensis tested, a MeOH extract and an EtOAc fraction were found to be potent inhibitors of rat lens aldose reductase (RLAR) in vitro - their IC50 values being 3.6 and 0.3 mu g/mL, respectively. From the active EtOAc fraction, four minor compounds with diverse structural moieties were isolated and identified as D-mannitol (1), 2,5-dihydroxybenzoic acid (2), delphinidin 3-O-beta-galactopyranoside-3',5'-di-O-beta-glucopyranoside (3), and delphinidin 3-O-beta- galactopyranoside-3'-O-beta-glucopyranoside (4). Among these, 4 was found to be the most potent RLAR inhibitor (IC50 = 0.23 mu g/mL), and may be useful in the prevention and/or treatment of diabetic complications. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | TAYLOR & FRANCIS LTD | - |
dc.subject | FLAVONOIDS | - |
dc.title | Aldose reductase inhibitors from Litchi chinensis Sonn | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Sung-Jae | - |
dc.identifier.doi | 10.1080/14756360802560867 | - |
dc.identifier.scopusid | 2-s2.0-76249133504 | - |
dc.identifier.wosid | 000269548700006 | - |
dc.identifier.bibliographicCitation | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, v.24, no.4, pp.957 - 959 | - |
dc.relation.isPartOf | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | - |
dc.citation.title | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | - |
dc.citation.volume | 24 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 957 | - |
dc.citation.endPage | 959 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.subject.keywordPlus | FLAVONOIDS | - |
dc.subject.keywordAuthor | Litchi chinensis | - |
dc.subject.keywordAuthor | rat lens aldose reductase inhibitor | - |
dc.subject.keywordAuthor | cataract | - |
dc.subject.keywordAuthor | delphinidin 3-O-B-galactopyranoside-3 &apos | - |
dc.subject.keywordAuthor | -O-beta-glucopyranoside | - |
dc.subject.keywordAuthor | diabetes | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.